Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti - Wikidata - wikimedia - TriplyDB

Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti

Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti

http://www.wikidata.org/entity/Q34031173

about

Cost-Effectiveness of Improving Health Care to People with HIV in Nicaragua.CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda.Superior outcomes and lower outpatient costs with scale-up of antiretroviral therapy at the GHESKIO clinic in Port-au-Prince, Haiti.Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria.Diagnosis of HIV-Associated Oral Lesions in Relation to Early versus Delayed Antiretroviral Therapy: Results from the CIPRA HT001 Trial Prioritizing health system and disease burden factors: an evaluation of the net benefit of transferring health technology interventions to different districts in Zimbabwe.The Haiti research-based model of international public health collaboration: the GHESKIO Centers.HIV in Africa: Challenges and Directions for the Next Decade.Early Treatment in HIV Patients: A Cost-Utility Analysis from the Italian Perspective.

P2860

Q33757712-324F27F4-FA15-46EE-90FD-3F44D02DE264 Q33882458-99E53BE5-BD73-48CD-B1C7-9C7BABE53B33 Q34775595-F45A90E5-7AD2-47AF-9FC9-5BFA90990A48 Q34998736-4EBD5906-3984-48B6-8438-E1510CD7565C Q35941275-49186279-B942-459C-9BBA-DECDEF59299C Q37446922-32272B29-087F-4789-B8EF-F38CC99373B8 Q37734587-9A57570D-BD34-4779-AD9E-FCF4AA6ED0C1 Q38419599-39C7977A-689D-4357-931B-8ACD0F52108B Q38759954-367F6FC5-3F7F-421B-AE5D-2780690D82EE

P2860

Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti

http://www.wikidata.org/entity/Q34031173

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cost-effectiveness of early ve ...... n HIV-infected adults in Haiti

@ast

Cost-effectiveness of early ve ...... n HIV-infected adults in Haiti

@en

Cost-effectiveness of early ve ...... n HIV-infected adults in Haiti

@nl

type

label

Cost-effectiveness of early ve ...... n HIV-infected adults in Haiti

@ast

Cost-effectiveness of early ve ...... n HIV-infected adults in Haiti

@en

Cost-effectiveness of early ve ...... n HIV-infected adults in Haiti

@nl

prefLabel

Cost-effectiveness of early ve ...... n HIV-infected adults in Haiti

@ast

Cost-effectiveness of early ve ...... n HIV-infected adults in Haiti

@en

Cost-effectiveness of early ve ...... n HIV-infected adults in Haiti

@nl

P1433

Q34031173-D47B7BC8-F798-4378-BA00-D6B4E743FAA8

P1476

Q34031173-E3ADB9E9-16FF-45C3-BE13-DFDD06D49AD3

P2093

Q34031173-1CBE6EB9-E7A0-480A-8C49-E0F72A401EA4

Q34031173-23AA884A-74E3-484C-B780-CB88B17C5A8C

Q34031173-3D4E8EBC-5F3A-4546-B0AE-CB3524182F08

Q34031173-41FB87E3-FAF5-4A2A-BF81-BC1A1043B95C

Q34031173-54E08046-5DBC-42A4-932D-ED2D802992CC

Q34031173-5B748D25-EBB1-4684-A200-F08855FA653F

Q34031173-7F0E7269-74A4-40B9-9013-09AE1DD190DE

Q34031173-9BBB4DF1-A00E-4044-9312-086B22ADA611

Q34031173-AF93BADE-F519-4AAE-92A4-BEDF895D3828

Q34031173-B354F25B-D01B-42C3-AA48-673360D5BF62

P2860

Q34031173-01ACE192-E007-4C31-A48C-55F10FEC2FAE

Q34031173-08A80A93-4F3B-4E30-B35A-3B5BEEDD1395

Q34031173-16E49CA3-E8F1-4916-A73F-ADAE05243290

Q34031173-25A6481F-E38F-41B4-BBE0-BD135C0C9ECC

Q34031173-2647FBDF-4A6F-4D11-92D9-C2F096E02B92

Q34031173-275E9349-78A3-45FA-A253-6650CAD5F275

Q34031173-2A30D0C0-BBCF-4272-B1EE-E5C7932DA482

Q34031173-2CCAF413-EC80-44E8-A5FF-EA2F5E2EE825

Q34031173-40DCA668-0929-4008-9D78-6C38D05B86C5

Q34031173-4595BF37-BE01-4053-B4FE-D00C12B8D24F

P304

Q34031173-F0D3B960-8955-4055-9983-751B632D38B0

P31

Q34031173-8E59245A-BB2F-4A01-AB2F-E1407A658DDD

P356

Q34031173-DA8EF6AE-4F82-484A-8A39-08D663051B7D

P407

Q34031173-F69568E5-8FD1-4EB9-B4D1-11907ECCB66C

P433

Q34031173-110CBC9B-2584-4C30-AC49-304A390F6867

P478

Q34031173-1A133D93-F762-46C3-A90D-855392E5F63B

P50

Q34031173-5261A642-5D50-49B1-BDAB-CA27A962D570

Q34031173-AD507490-7F91-4950-93F0-8720411D6393

Q34031173-DB5B21E9-7276-47DD-8D70-5B1B0F38BCC5

P577

Q34031173-1595A177-50F9-476D-B15B-1470CFED101F

P5875

Q34031173-3DDCF0E8-CDD9-496D-A969-716DA169586C

P698

Q34031173-FDE5DEE1-606E-4F20-AB5C-F7F06DBB48C4

P921

Q34031173-477A0415-D893-4572-A363-AB132960FD95

Q34031173-DC3F78EF-C2F3-4D9B-AE0B-A668DC5696C0

P932

Q34031173-62163336-7644-4483-B7D3-C0CC21DD849E

P356

JOURNAL.PMED.1001095

P1433

P1476

Cost-effectiveness of early ve ...... n HIV-infected adults in Haiti

@en

P2093

Alex Ambroise

http://www.w3.org/2001/XMLSchema#string

Alison Edwards

http://www.w3.org/2001/XMLSchema#string

Bruce R Schackman

http://www.w3.org/2001/XMLSchema#string

Cynthia Riviere

http://www.w3.org/2001/XMLSchema#string

Heejung Bang

http://www.w3.org/2001/XMLSchema#string

Jessica Hippolyte

http://www.w3.org/2001/XMLSchema#string

Jolion McGreevy

http://www.w3.org/2001/XMLSchema#string

Marc Antoine Jean Juste

http://www.w3.org/2001/XMLSchema#string

Rode Secours

http://www.w3.org/2001/XMLSchema#string

Serena P Koenig

http://www.w3.org/2001/XMLSchema#string

P2860

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

On estimating medical cost and incremental cost-effectiveness ratios with censored data.

On the equivalence of some medical cost estimators with censored data.

Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting.

Cost analysis with censored data

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.

Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa

Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.

P304

e1001095

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.1001095

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Jean William Pape

Daniel W Fitzgerald

P577

2011-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51665568

http://www.w3.org/2001/XMLSchema#string

P698

21949643

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3176754

http://www.w3.org/2001/XMLSchema#string